Resmed Inc. (NYSE:RMD)’s traded shares stood at 3.28 million during the last session, with the company’s beta value hitting 0.69. At the close of trading, the stock’s price was $256.07, to imply an increase of 7.12% or $17.02 in intraday trading. The RMD share’s 52-week high remains $255.18, putting it 0.35% up since that peak but still an impressive 48.36% since price per share fell to its 52-week low of $132.24. The company has a valuation of $37.58B, with an average of 1.2 million shares in intraday trading volume over the past 10 days and average of 1.02 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Resmed Inc. (RMD), translating to a mean rating of 2.08. Of 19 analyst(s) looking at the stock, 1 analyst(s) give RMD a Sell rating. 0 of those analysts rate the stock as Overweight while 8 advise Hold as 10 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 2.27.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Resmed Inc. (NYSE:RMD) trade information
After registering a 7.12% upside in the last session, Resmed Inc. (RMD) has traded red over the past five days. The 5-day price performance for the stock is 6.70%, and 5.57% over 30 days. With these gigs, the year-to-date price performance is 48.86%. Short interest in Resmed Inc. (NYSE:RMD) saw shorts transact 8.57 million shares and set a 7.94 days time to cover.
The extremes give us $175 and $280 for target low and target high price respectively. As such, RMD has been trading -9.35% off suggested target high and 31.66% from its likely low.
Resmed Inc. (RMD) estimates and forecasts
Looking at statistics comparing Resmed Inc. share performance against respective industry, we note that the company has outperformed competitors. Resmed Inc. (RMD) shares are 17.43% up over the last 6 months, with its year-to-date growth rate higher than industry average at 17.62% against 11.50%. Revenue is forecast to grow 20.70% this quarter before jumping 10.80% for the next one. The rating firms project that company’s revenue will grow 7.60% compared to the previous financial year.
Revenue forecast for the current quarter as set by 12 analysts is 1.25B. Meanwhile, for the current quarter, a total of 12 analyst(s) estimate revenue growth to 1.29B.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 19.83% for the past 5-year period. While 2024 is set for a 20.78% return in earnings, projections for the next 5 years are at 15.00% annually.
RMD Dividends
Resmed Inc. has its next earnings report out on 2025-Jan-22. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Resmed Inc. has a forward dividend ratio of 1.97, with the share yield ticking at 0.77% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.84%.
Resmed Inc. (NYSE:RMD)’s Major holders
Resmed Inc. insiders hold 0.79% of total outstanding shares, with institutional holders owning 60.41% of the shares at 60.89% float percentage. In total, 60.41% institutions holds shares in the company, led by VANGUARD GROUP INC. As of 2024-06-30, the company held over 17.9 million shares (or 12.1805% of shares), all amounting to roughly $3.43 billion.
The next major institution holding the largest number of shares is BLACKROCK INC. with 11.69 million shares, or about 7.9559% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $2.24 billion.
We also have Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund as the top two Mutual Funds with the largest holdings of the Resmed Inc. (RMD) shares. Going by data provided on Jun 30, 2024 , Vanguard Total Stock Market Index Fund holds roughly 4.65 shares. This is just over 3.17% of the total shares, with a market valuation of $1.19 billion. Data from the same date shows that the other fund manager holds a little less at 3.77, or 2.57% of the shares, all valued at about 965.5 million.
